MVMarc Vigny

Marc Vigny

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marc Vigny has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Boussad Souttou

    INSERM U 440/ UPM, Signalisation et Différenciation Cellulaires dans les Systèmes Nerveux et Musculaire, Institut du Fer à Moulin, 17 rue du Fer à Moulin, F-75005, Paris, France

    2 shared publications
  • Daniel Raulais

    INSERM U 440/ UPM, Signalisation et Différenciation Cellulaires dans les Systèmes Nerveux et Musculaire, Institut du Fer à Moulin, 17 rue du Fer à Moulin, F-75005, Paris, France

    2 shared publications
  • Heikki Rauvala

    Neuroscience Center, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland

    1 shared publication
  • Nicole Brunet-De Carvalho

    INSERM U 440/ UPM, Signalisation et Différenciation Cellulaires dans les Systèmes Nerveux et Musculaire, Institut du Fer à Moulin, 17 rue du Fer à Moulin F-75005 Paris, France

    1 shared publication

Latest Publications

  • HB-GAM/Pleiotrophin and Midkine are Differently Expressed and Distributed During Retinoic Acid-induced Neural Differentiation of P19 Cells

    by Nicole Brunet-De Carvalho, Daniel Raulais, Heikki Rauvala, Boussad Souttou, Marc Vigny

    HB-GAM/Pleiotrophin and Midkine (MK) are developmentally-regulated proteins with putative functions during cell growth and differentiation. Using the P19 cell which is a model to study the events associated with early development, we examined the expression and cellular localization of HB-GAM and MK during neural differentiation of P19 cells induced by retinoic acid (RA). The temporal expressions of HB-GAM and MK transcripts and both the levels and cellular localizations of the corresponding proteins appeared dramatically different. MK mRNA, already expressed in untreated P19 cells, was transiently increased by exposure to RA and then largely down regulated. More interestingly, HB-GAM which was not detected in untreated P19 cells was strongly expressed after 2 days of RA treatment and this expression persists throughout the duration of the culture suggesting that it could be involved in different aspects of this differentiation process.


  • Pleiotrophin induces angiogenesis: Involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways

    by Boussad Souttou, Daniel Raulais, Marc Vigny

    Pleiotrophin (PTN) is a developmentally regulated protein that has been shown to be involved in tumor growth and metastasis presumably by activating tumor angiogenesis. To clarify the potential angiogenic activity of PTN and to analyze the signaling pathways involved in this process, we used an in vitro model of Human Umbilical Vein Endothelial Cells (HUVEC). We show that PTN was mitogenic toward a variety of endothelial cells including HUVEC, stimulated HUVEC migration across a reconstituted basement membrane and induced the formation of capillary‐like structures by HUVEC grown as 3D‐cultures in Matrigel or collagen. The signaling pathways triggered following endothelial cell stimulation by PTN were studied by using pharmacological inhibitors of the Phosphoinositide‐3 kinase (PI3K) and endothelial Nitric Oxide Synthase (eNOS), two enzymes that have been shown to be crucial in the angiogenic response to Vascular Endothelial Growth Factor (VEGF). Whereas wortmannin (a PI3K inhibitor) and L‐NAME (an eNOS inhibitor) dramatically reduced HUVEC growth induced by VEGF, only the former inhibitor reduced the growth induced by PTN and to a lesser extent that stimulated by basic Fibroblast Growth Factor. Thus, our results indicate that PTN induces angiogenesis and utilizes PI3K‐ but not eNOS‐dependent pathways for its angiogenic activity.